Stay updated on Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial
Sign up to get notified when there's something new on the Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial page.

Latest updates to the Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedVersion v3.5.4 has been added to the Study Record Versions list. The previous version v3.5.3 has been removed, updating the history to reflect the latest revision.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA new revision entry v3.5.3 was added to the Record History, and the previous revision v3.5.2 was removed. This updates the version history to reflect the latest revision of the study record.SummaryDifference0.1%

- Check38 days agoChange DetectedRevision: v3.5.2 is now listed, replacing v3.5.0, indicating a minor version update to the page history.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page's revision metadata was updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision: v3.4.3 was added to the history. Revision: v3.4.2 was removed.SummaryDifference0.1%

- Check103 days agoChange DetectedAdded Revision: v3.4.2 to the study record history. Removed the government-funding notice and Revision: v3.4.1 entry.SummaryDifference0.6%

Stay in the know with updates to Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial page.